Corona Virus #7

Status
Not open for further replies.
/ Corona Virus #7 #101  
I've been to a couple of grocery stores in the past couple of weeks. I don't see staff interacting with customers much at all. The deli counter and meat counter where you would have conversations with the staff have been shut down temporarily. The cashiers at check out are protected by a 4ft by 4ft plexiglass barrier. I imagine most restocking is still done at night when customers are gone. The staff at most "risk" of being close to customers are the produce guys who are constantly refilling bins of produce.

Look for online ordering and "call us when you're in the parking lot and we'll load your groceries" expedited pick up to become a much bigger deal in the months ahead ... might even become a thing ...

Order Acme
 
/ Corona Virus #7 #102  
Interesting ... there were just 5 threads outside of FP spammed with political content ... with links containing malware.
 
/ Corona Virus #7 #103  
1) The key issue here is the value of an "open-label non-randomized clinical trial". FDA never accepts these as they are chock full of uncontrolled bias that can be difficult to weed out. It is a fancy way of saying "I gave the drug to whomever I wanted to and excluded patients I didn't want to get it for whatever reason". In addition, in this paper it is clear that they didn't even have a control group in their own hospital. They used a different hospital for controls. That is almost never acceptable as you don't know what the differences in patient populations are. For example, one hospital might be a middle class referral center (think Mayo Clinic) and the other might be an inner city gun and knife club filled with addicts and poorly nourished patients (this is obviously and extreme example). You simply cannot legitimately use a control from another facility unless you know the hospital populations are very similar and that the criteria for admission, testing, supportive care, laboratory quality etc etc are the same. The fact that the study wasn't randomized means that the investigators get to choose who they treat and that simple fact introduces another whole type of potential bias called selection bias. The type of study done by the French is equivalent to cherry picking opinions on the Internet without knowing anything about the people posting. Not a good idea. That's why FDA insists on double blind (investigator nor patient knows whether they get the experimental drug or placebo so there cannot be bias in assessing the effectiveness later) and randomized (investigator doesn't get to choose who gets put in which arm of the trial).

Regarding the journal International Journal of Antimicrobial Agents: not a top tier journal for starters. Not terrible but not read nearly as much as Lancet, NEJM or a couple of dozen infectious disease journals etc etc. Why not publish in a more widely read journal if you are trying to get the word out??? Several reasons. For starters it is the type of trial that rarely is published anymore for the reasons I just reviewed. Another reason is that that journal is run by an editor who is in Marseille the same city where the study is done. Home town advantage?? I would not consider this to have been a peer reviewed study based on what I can see. It is more likely an old boy's club review and as the senior author is a well known politically powerful character, I doubt it was a vigorous review at all.

I agree it isn't a complete study. In fact it needs to be completely redesigned in order to generate any useful data. Randomized double blinded controlled trial with external review. Fair enough to point out that such a trial would take more time (but not that much more) but knowing that an anecdotal report (which is all that an open-label non-randomized clinical trial is) is next to useless in making serious medical decisions, it should never have been presented as something that should be immediately adopted. I don't expect Trump to know that but Trump should know to listen to Fauci and Fauci knows exactly that which is why he refused to endorse chloroquine.

I was half joking about the appearance of the senior author and indeed I pointed out that I have worked with some pretty weird looking scientists who I hold in high regard. Einstein didn't announce his theories on YouTube!
I don't disagree at all with your points about selection bias, unmatched controls, etc. Those are certainly limitations of the study. But, ask yourself, then, why you didn't perform a better study?

Your answer may be quite revealing. I'm guessing it will be somewhat along the lines of, "I don't have the expertise", or "I don't have access to the needed patient population," or "I don't have the funding to run the study," etc. Quite frankly, I applaud the authors for doing what they could with the data they have. I find casting aspersions from afar detrimental, negative, and not helpful. If you don't think the study was done right, then do it yourself, correct the mistakes, and publish it.

Finally, the study also doesn't claim to be a final say on whether the approach is or is not effective. Quite the opposite, there are many comments along the lines of "Our preliminary results show ...", and "further studies on the combined effect are needed ..."

Again, the study has some serious flaws and shortcomings, but what it does do is provide compelling evidence that there may be targeted approaches that could lead to success.
 
/ Corona Virus #7 #104  
Interesting ... there were just 5 threads outside of FP spammed with political content ... with links containing malware.

I clicked on one of them but stopped before before it opened.
 
/ Corona Virus #7
  • Thread Starter
#105  
Again, the study has some serious flaws and shortcomings, but what it does do is provide compelling evidence that there may be targeted approaches that could lead to success.
Especially considering the circumstances... seems quite a few people are facing a life threatening situation in the short term. It probably is not the long term solution but seems worth it to continue to explore and 'experiment' as a short term treatment.
 
/ Corona Virus #7 #107  
Agree...but if they are looking for easy targets...they move on elsewhere. The public road dead ends at my gate. There is a turn off for a two track about 150 yards before my gate. So "traffic" is non existent except during snowmobile or off-roading seasons.

I have "met" trucks heading to our place before and always ask, "Are you lost? Do you need directions?"

Tell them a lot of your neighbors have been noticing them and one is always seeing the truck with his plate number on his camera.
If they’re trouble and their anonymity is gone and they know they’re being watched, they’ll move on to easier pickings.
 
/ Corona Virus #7 #109  
How long do you think we can go before we have to restart the economy regardless of how many die?

Chris
 
/ Corona Virus #7 #110  
I don't disagree at all with your points about selection bias, unmatched controls, etc. Those are certainly limitations of the study. But, ask yourself, then, why you didn't perform a better study?

Your answer may be quite revealing. I'm guessing it will be somewhat along the lines of, "I don't have the expertise", or "I don't have access to the needed patient population," or "I don't have the funding to run the study," etc. Quite frankly, I applaud the authors for doing what they could with the data they have. I find casting aspersions from afar detrimental, negative, and not helpful. If you don't think the study was done right, then do it yourself, correct the mistakes, and publish it.

Finally, the study also doesn't claim to be a final say on whether the approach is or is not effective. Quite the opposite, there are many comments along the lines of "Our preliminary results show ...", and "further studies on the combined effect are needed ..."

Again, the study has some serious flaws and shortcomings, but what it does do is provide compelling evidence that there may be targeted approaches that could lead to success.

Keep in mind there are doers and there are others that focus on knocking the efforts of the doers. Every doctor knows the best sources from time to time print junk studies. Peer review is a good thing unless there are behind the scene agreements like you support my research and I will support your research so we both have a shot at another round of grants.
 
/ Corona Virus #7 #111  
Wow early June... thinking that is the longest duration of any state now.

When SF Shelter in Place for 2 weeks signed on March 17th some of the Docs I work with said this will go on for months but to reduce panic it was rolled out incrementally... much easier to say 2 weeks instead of coming out saying 10 weeks.
 
/ Corona Virus #7 #112  
How long do you think we can go before we have to restart the economy regardless of how many die?

Chris

Apparently there is no reason to act like the corona virus is such a big deal. 520,000 Americans die every year due to smoking, and the government is more than happy to tax that habit and take the money to the bank. So, what is the big deal here?

Cigarette smoking is responsible for more than 480,000 deaths per year in the United States, including more than 41,000 deaths resulting from secondhand smoke exposure. This is about one in five deaths annually, or 1,300 deaths every day. On average, smokers die 10 years earlier than nonsmokers.Nov 28, 2018

Fast Facts | Fact Sheets | Smoking & Tobacco Use | CDCwww.cdc.gov › tobacco › data_statistics ›
 
/ Corona Virus #7 #113  
I don't disagree at all with your points about selection bias, unmatched controls, etc. Those are certainly limitations of the study. But, ask yourself, then, why you didn't perform a better study?

Your answer may be quite revealing. I'm guessing it will be somewhat along the lines of, "I don't have the expertise", or "I don't have access to the needed patient population," or "I don't have the funding to run the study," etc. Quite frankly, I applaud the authors for doing what they could with the data they have. I find casting aspersions from afar detrimental, negative, and not helpful. If you don't think the study was done right, then do it yourself, correct the mistakes, and publish it.

Finally, the study also doesn't claim to be a final say on whether the approach is or is not effective. Quite the opposite, there are many comments along the lines of "Our preliminary results show ...", and "further studies on the combined effect are needed ..."

Again, the study has some serious flaws and shortcomings, but what it does do is provide compelling evidence that there may be targeted approaches that could lead to success.

I understand your comments. Perhaps the main thing that bothers me is how they publicized their work to a frightened global public via YouTube rather than addressing the many methodological issues identified and then focusing on doing a better second generation study. This “jumping the gun” type of approach to medicine has over the years created all sorts of mischief and tragedy. Had they presented their preliminary data to someone like Fauci and asked for research support to do a proper trial then I would feel very differently. As it is I think the guy is just confirming his reputation as a first rate self promoter and second rate clinical scientist. That apparently is exactly how he is thought of by the biomedical community in France.
 
/ Corona Virus #7 #114  
Tuesday morning from FORTRESS TASMANIA! All is quiet. The PM (in conjunction with all of the State Premiers/Territory First Ministers) has now put into force no public gatherings of more than two (2) people. We (Australia) are taking the 'long view' and are preparing for, at least, a six (6) month strategy. The financial plan/budget is going to take decades to recover from as we're taking the attitude that this fight has two fronts: a) the virus, and b) the economy.

We're NOT in "lockdown", per se. If you're not in an essential job, stay home and self-isolate. Plan a weekly trip to get your groceries/pharmaceuticals/mail/petrol/etc... and 'make a list' of what you're going to get so that you don't linger.

Tassie recorded our first death yesterday, a woman in her 80's. There are 69 cases in the State. 18 deaths for the entire country as of today.
-----------------------------------------------------

Some TBNers may recall that my Aunt is on the cruise ship MS ZAANDAM. She's OK and the ship has now moved through the Panama Canal and is in the Caribbean on their way to Florida.
 
/ Corona Virus #7 #117  
This Corona lockdown has got me doing things I have not done in years... like making hash browns. It has been probably 10 years.
FDB19C16-FDD9-4BE7-A0DD-66DC4E23BC7A.jpeg 926CE0F4-04BF-4D0D-91F6-6557E5566E08.jpeg 9297536A-DC6C-4EB2-B218-B34A49A3D95F.jpeg
 
/ Corona Virus #7 #118  
I understand your comments. Perhaps the main thing that bothers me is how they publicized their work to a frightened global public via YouTube rather than addressing the many methodological issues identified and then focusing on doing a better second generation study. This å±*umping the gun type of approach to medicine has over the years created all sorts of mischief and tragedy. Had they presented their preliminary data to someone like Fauci and asked for research support to do a proper trial then I would feel very differently. As it is I think the guy is just confirming his reputation as a first rate self promoter and second rate clinical scientist. That apparently is exactly how he is thought of by the biomedical community in France.

As an academic research scientist, I fully understand the concerns. However, the sad state of the matter is that self-promotion and science go hand-in-hand in today's research climate. If you aren't self-promoting, making strategic connections, etc., your chance for continued research productivity through a steady stream of funding is about zero. I can't count the number of program managers that have told me, "I'm not funding a project/research question based on the scientific merit, I'm funding an individual." That doesn't mean I agree with that approach (I find it very disappointing), just that it's a necessary evil.

I think where part of the backlash comes from is the sheer amount of publicity that was received in the public media, which then outraged everyone else. I'm sure a fair amount of that is jealousy as well. "Why was their study highlighted by news media, and mine not?". I doubt the authors even anticipated the amount of traction they would get from that study. I regularly read peer-reviewed journal articles that are more flawed and more outlandish in their claims than what this study was. That still doesn't mean there isn't useful information that can be gleaned from them. As a scientist, our goal is to find the truth, and move it forward. There can be useful information in very flawed studies. In most cases, scientists reading the articles and doing research in related fields recognize this and can distinguish between claims that are backed up by the data, and those that are speculative.

A level head in response to all research claims (good and/or bad) is needed to move scientific fields forward in a methodical and progressive manner. This is not effectively accomplished by striving to tear down others based on ones perceived views of their flaws. Most scientists realize how small their respective research communities are, and that a respectful, collegial approach is needed by all. If not, as one researcher once told me, "it quickly turns into a circular firing squad." You see those exact behaviors exhibited on this forum. What is this, CoronaVirus thread #7?!?!
 
/ Corona Virus #7 #119  
Agree. If it turns out that people die because we run out of ventilators, I'd like to see a Congressional investigation of the corporate decision making that resulted in the cancelation of the cheap "good enough" ventilator project. Nothing wrong with profits unless they directly hurt the public health.
Firstly, if the US taxpayer is funding a cheap "good enough" ventilator project, part of the agreement should have been that the government ends up with the blueprints and all the data related to the project no matter what happens with the project and if the company decides not to pursue it, they give up all rights to it.

Aaron Z
 
/ Corona Virus #7 #120  
Status
Not open for further replies.
 
Top